Home / Pharmaceuticals / Sterile Injectables Market By Drug Type (Monoclonal Antibodies, Cytokines, Insulin, Immunoglobulin, Vaccines, Peptide Hormones, Peptide Antibiotics, Blood Factors and Others), By Therapeutic Area (Cancer, Infectious Diseases, Diabetes, Cardiovascular Diseases, Neurological Diseases, Musculoskeletal Diseases and Others) - Growth, Future Prospects and Competitive Analysis, 2017 - 2025

Sterile Injectables Market By Drug Type (Monoclonal Antibodies, Cytokines, Insulin, Immunoglobulin, Vaccines, Peptide Hormones, Peptide Antibiotics, Blood Factors and Others), By Therapeutic Area (Cancer, Infectious Diseases, Diabetes, Cardiovascular Diseases, Neurological Diseases, Musculoskeletal Diseases and Others) - Growth, Future Prospects and Competitive Analysis, 2017 - 2025

Published: Nov 2017 | Report Code: 58818-11-17

Sterile injectables market is rising with growing demand for biologics in order to treat numerous medical conditions with immediate and effective outcomes. Widening application of injectables have transformed medical treatments as higher quality of sterile injectables have lowered chances of risk or any contamination.

Growing prevalence of cancer and chronic diseases contributed to the growth of sterile injectables market. Surging demand for biologics and increasing trend of biosimilars act as major growth factors of sterile injectables market. Expanding usage of generic injectables in pen-filled syringes, pre-filled syringes in medical settings have also boost the market growth. However, low-quality injectables product, inconsistent product launches and recall of substandard products were few reasons behind the global issues of major drug shortage which further caused severe disadvantage to patients and healthcare providers. High cost of automation in product development in order to manufacture improved sterile injectables and stringent regulatory guidelines of product approval have created challenges to the manufacturers which in turn restrain the market growth. Focus on broadened product portfolio with pipeline products and restructuring by mergers and acquisition activities of key players are expected to fuel the future growth of sterile injectables market.

The scope of the research report titled ‘Sterile Injectables Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, company executives, developers and industry experts with detailed analysis of market to take strategic initiatives and business decisions regarding to the prospects of global sterile injectables market. Major market trends prevalent in the global sterile injectables market and the market size of present and forecast periods have been presented in the research report. Global health concern, increasing research expenditure, utilization of advanced technology and product innovation strongly boost the growth of sterile injectables market.

This report contains the global sterile injectables market in terms of drugs type, therapeutic areas and geographical distribution. Based on drug types, the sterile injectables market is segmented into monoclonal antibodies, cytokines, insulin, immunoglobulin, vaccines, peptide hormones, peptide antibiotics, blood factors and others. On the basis of therapeutic areas, the sterile injectables market has been classified as cancer, infectious diseases, diabetes, cardiovascular diseases, neurological diseases, musculoskeletal diseases and others.

On the basis of geography, the sterile injectables market is classified into five major regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa which are further categorized into major country-specific markets. North America region consists of the data for the United States and Canada; whereas the United Kingdom, Germany and rest of Europe have been considered in European region. Asia Pacific encompasses the information for China, Japan, India and rest of Asia Pacific markets. Latin America is cross-sectioned into Brazil, Mexico and other LATAM countries and Middle East and Africa is segmented into GCC, South Africa and other MEA countries. Market size and forecast of every mentioned geography for 2015-2025 along with CAGRs for the forecast period 2017-2025 have been presented in this research report. Furthermore, the considered regional markets are further cross-sectioned on the basis of drug types, and therapeutic areas.

This research study also provides insights in terms of market dynamics factors such as market drivers, restrains and opportunity of present and predicted market of sterile injectables to deploy suitable business strategies. Comprehensive details of competitive assessment tools like partnerships, major agreements, collaborations, mergers and acquisition activities, joint ventures, market attractiveness and competitive landscape analysis by major players are also stated in the report for better understanding purpose. This report comprises of the detailed profiling of few of the major players like Pfizer Inc., Mylan N.V, Baxter International Inc., Novartis AG, AstraZeneca plc., Amgen Limited, Merck & Co., Inc., Johnson & Johnson Services, Inc., Nichi-Iko Pharmaceutical Co., Sanofi, Eli Lilly and Company.

Sterile Injectables Market

 

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Sterile Injectables Market Portraiture
2.1.1. Global Sterile Injectables Market, by Drug Type, 2016 (US$ Mn)
2.1.2. Global Sterile Injectables Market, by Therapeutic Area, 2016 (US$ Mn)
2.1.3. Global Sterile Injectables Market, by Geography, 2016 Vs. 2025 (Value %)

Chapter 3. Sterile Injectables Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Sterile Injectables: Future Trends
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2016
3.7. Major Agreements, Partnerships and Collaborations
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition: Global Sterile Injectables Market, by Drug Type, 2016
4.2. Monoclonal Antibodies
4.3. Cytokines
4.4. Insulin
4.5. Immunoglobulin
4.6. Vaccines
4.7. Peptide Hormones
4.8. Peptide Antibiotics
4.9. Blood Factors
4.10. Others

Chapter 5. Global Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Sterile Injectables Market, by Therapeutic Area, 2016
5.2. Others Cancer
5.3. Infectious Disease
5.4. Diabetes
5.5. Cardiovascular Disease
5.6. Neurological Disease
5.7. Musculoskeletal Disease
5.8. Others

Chapter 6. Global Sterile Injectables Market, by Geography, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. North America Sterile Injectables Market Analysis, 2015 – 2025
6.2.1. North America Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.2.2. North America Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
6.2.3. North America Sterile Injectables Market, by Country, 2015 – 2025 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Sterile Injectables Market Analysis, 2015 – 2025
6.3.1. Europe Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.3.2. Europe Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
6.3.3. Europe Sterile Injectables Market, by Country, 2015 – 2025 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Sterile Injectables Market Analysis, 2015 – 2025
6.4.1. Asia Pacific Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.4.2. Asia Pacific Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
6.4.3. Asia Pacific Sterile Injectables Market, by Country, 2015 – 2025 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. India
6.4.3.4. Rest of APAC
6.5. Latin America Sterile Injectables Market Analysis, 2015 – 2025
6.5.1. Latin America Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.5.2. Latin America Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
6.5.3. Latin America Sterile Injectables Market, by Country, 2015 – 2025 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Sterile Injectables Market Analysis, 2015 – 2025
6.6.1. MEA Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.6.2. MEA Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
6.6.3. MEA Sterile Injectables Market, by Country, 2015 – 2025 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. South Africa
6.6.3.3. Rest of MEA

Chapter 7. Company Profiles
7.1. Amgen Limited
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. AstraZeneca plc.
7.3. Baxter International, Inc.
7.4. Eli Lilly and Company
7.5. Johnson & Johnson Services, Inc.
7.6. Merck & Co., Inc.,
7.7. Mylan N.V.
7.8. Nichi-Iko Pharmaceutical Co.
7.9. Novartis AG
7.10. Pfizer, Inc.
7.11. Sanofi

List of Tables

TABLE 1 Global Sterile Injectables Market Portraiture
TABLE 2 Global Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 3 Global Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
TABLE 4 Global Sterile Injectables Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 5 North America Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 6 North America Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
TABLE 7 North America Sterile Injectables Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 8 Europe Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
TABLE 10 Europe Sterile Injectables Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 11 Asia Pacific Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 12 Asia Pacific Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific Sterile Injectables Market, by Country, 2015 – 2025 (US$ Mn
TABLE 14 Latin America Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 15 Latin America Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
TABLE 16 Latin America Sterile Injectables Market, by Country, 2015 – 2025 (US$ Mn
TABLE 17 Middle East and Africa Sterile Injectables Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 18 Middle East and Africa Sterile Injectables Market, by Therapeutic Area, 2015 – 2025 (US$ Mn)
TABLE 19 Middle East and Africa Sterile Injectables Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 20 Amgen Limited: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 AstraZeneca plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Baxter International Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Eli Lilly and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Johnson & Johnson Services, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Mylan N.V: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Nichi-Iko Pharmaceutical Co.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Pfizer Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 Sanofi: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage

List of Figures

FIG. 1 Sterile Injectables: Market Segmentation
FIG. 2 Global Sterile Injectables Market Share, by Drug Type, 2016 (US$ Mn)
FIG. 3 Global Sterile Injectables Market Share, by Therapeutic Area, 2016 (US$ Mn)
FIG. 4 Global Sterile Injectables Market, by Geography, 2016 Vs. 2025 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography, 2016
FIG. 6 Market Competition Landscape, by Key Players, 2016
FIG. 7 Global Sterile Injectable Monoclonal Antibodies Market, 2015 – 2025 (US$ Mn)
FIG. 8 Global Sterile Injectable Cytokines Market (US$ Mn), 2015 – 2025 (US$ Mn)
FIG. 9 Global Insulin Sterile Injectable Insulin Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Sterile Injectable Immunoglobulin Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Sterile Injectable Vaccines Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Sterile Injectable Peptide Hormones Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Sterile Injectable Peptide Antibiotics Market, 2015 – 2025 (US$ Mn)
FIG. 14 Global Sterile Injectable Blood Factors Market, 2015 – 2025 (US$ Mn)
FIG. 15 Global Other Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 16 Global Sterile Injectables Market for Cancer Therapy, 2015 – 2025 (US$ Mn)
FIG. 17 Global Sterile Injectables Market for Infectious Disease Treatment, 2015 – 2025 (US$ Mn)
FIG. 18 Global Sterile Injectables Market for Diabetes Treatment, 2015 – 2025 (US$ Mn)
FIG. 19 Global Sterile Injectables Market for Cardiovascular Diseases Treatment, 2015 – 2025 (US$ Mn)
FIG. 20 Global Sterile Injectables Market for Neurological Diseases Treatment, 2015 – 2025 (US$ Mn)
FIG. 21 Global Sterile Injectables Market for Musculoskeletal Diseases Treatment, 2015 – 2025 (US$ Mn)
FIG. 22 Global Sterile Injectables Market for Other Therapeutic Areas, 2015 – 2025 (US$ Mn)
FIG. 23 U.S. Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 24 Canada Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 25 U.K. Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 26 Germany Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 27 Rest Of Europe Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 28 Japan Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 29 China Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 30 India Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 31 Rest Of Asia Pacific Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 32 Brazil Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 33 Mexico Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 34 Rest Of Latin America Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 35 GCC Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 36 South Africa Sterile Injectables Market, 2015 – 2025 (US$ Mn)
FIG. 37 Rest Of Middle East And Africa Sterile Injectables Market, 2015 – 2025 (US$ Mn)

The sterile injectables market is classified on the basis of therapeutic area types and the classes are as below:

  • Cancer
  • Infectious Diseases
  • Diabetes
  • Cardiovascular Diseases
  • Neurological Diseases
  • Musculoskeletal Diseases
  • Others

Among all the therapeutic areas, cancer and infectious diseases are estimated to be the dominating segments. Sterile injectables have been proven successful in delivering better treatment outcomes in various cancers such as lymphoma, cervical cancer and testicular cancer. As per the statistics of the National Cancer Institute, there were around 14 million new cases of cancer in the year 2012; and cancer being the world’s leading cause of death, improved measures have been taken for prevention, diagnosis and treatment procedures among public healthcare providers. Diabetes is considered to be responsible for around 1.5 million deaths in the year 2012 and such high prevalence increases the demand for sterile injectables for treatment purpose. The growing trend of chronic ailments like cardiovascular diseases, neurological diseases has also boost the growth of sterile injectables market as a result of benefits such as faster recovery and lesser side effects. Increasing rate of musculoskeletal disorder causes significant health issues among the workers of United States and European region where sterile injectables are used for long-term relief, which thus acts as key driver for the growth of sterile injectables market.

Sterile Injectables Market

The sterile injectables market is categorized on the basis of drug types and the categories are:

  • Monoclonal Antibodies
  • Cytokines
  • Insulin
  • Immunoglobulin
  • Vaccines
  • Peptide Hormones
  • Peptide Antibiotics
  • Blood Factors
  • Other Drugs

The major share of sterile injectables is contributed by monoclonal antibodies, followed by vaccines and insulin owing to increasing awareness among public and growing application areas. The key driver of monoclonal antibody injectables market is increasing prevalence of cancer, respiratory diseases like asthma, infectious diseases and autoimmune diseases like rheumatoid arthritis. Growing demand for monoclonal antibodies is on rise due to proper dosing frequency for any treatment, potential therapeutics and target of specific antigen. Diabetes caused 1.6 million deaths worldwide in the year 2015; such high prevalence of diabetes has increased the market for insulin injectables. Governments and healthcare organizations have taken various initiatives in order to develop improved healthcare system, which drives the growth of sterile injectables market especially vaccine. Injectable vaccines is predicted to witness lucrative growth as a result of development of innovative therapeutic vaccines for disease prevention and their increasing adoption among patients due to offered convenience. Cytokine imbalance causes multiple diseases; therefore injectable cytokine therapy significantly conquer multiple disease progression and therefore influence the growth of the sterile injectables market.

Sterile Injectables Market

Geographically, the global sterile injectables market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Sterile Injectables Market

North America is considered to be the leading region in terms of revenue of global sterile injectables market since the U.S. is the main outsourcing destination of sterile injectables. North America is predicted to witness steady growth owing to developed healthcare infrastructure, growing prevalence of cancer, diabetes and emerging health awareness among public. The imbalance in demand-supply equation has affected the sterile injectables market in North America, which has opened penetration opportunity of the manufacturers from other developing countries. The growth opportunity of sterile injectables market in North America is driven by presence of major manufacturers and their market consolidation activities. However, regulatory guidelines and stringent inspection of FDA sometimes act as barriers to new product launch, which in turn restrain the growth of sterile injectables market. The sterile injectables market in Europe is driven by improved product formulation, increasing demand and growing contract manufacturing options.

Asia Pacific is anticipated to witness the fastest growth during upcoming years on the account of developing healthcare infrastructures, emerging economies, and gradual growth in health awareness among public. Market penetration of Western pharmaceuticals manufacturers, changing regulatory guidelines, new product innovation and commercialization, and contract manufacturing are expected to support significant growth of sterile injectables market in Asia Pacific region. Growing interest among Asian manufacturers in terms of manufacturing generic injectables is expected to positively influence global sterile injectables market.

Regional classification of the global sterile injectables market is presented as follows:

  • North America (The United States & Canada)
  • Europe (The United Kingdom, Germany, and rest of European countries)
  • Asia Pacific (India, Japan, China and rest of Asia Pacific countries)
  • Latin America (Mexico, Brazil, and rest of LATAM countries)
  • Middle East and Africa (GCC, South Africa and rest of MEA countries)

The sterile injectables market is categorized on the basis of drug types and the categories are:

·         Monoclonal Antibodies

·         Cytokines

·         Insulin

·         Immunoglobulin

·         Vaccines

·         Peptide Hormones

·         Peptide Antibiotics

·         Blood Factors

·         Other Drugs

The major share of sterile injectables is contributed by monoclonal antibodies, followed by vaccines and insulin owing to increasing awareness among public and growing application areas. The key driver of monoclonal antibody injectables market is increasing prevalence of cancer, respiratory diseases like asthma, infectious diseases and autoimmune diseases like rheumatoid arthritis. Growing demand for monoclonal antibodies is on rise due to proper dosing frequency for any treatment, potential therapeutics and target of specific antigen. Diabetes caused 1.6 million deaths worldwide in the year 2015; such high prevalence of diabetes has increased the market for insulin injectables. Governments and healthcare organizations have taken various initiatives in order to develop improved healthcare system, which drives the growth of sterile injectables market especially vaccine. Injectable vaccines is predicted to witness lucrative growth as a result of development of innovative therapeutic vaccines for disease prevention and their increasing adoption among patients due to offered convenience. Cytokine imbalance causes multiple diseases; therefore injectable cytokine therapy significantly conquer multiple disease progression and therefore influence the growth of the sterile injectables market

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients